APOLIPOPROTEIN A-1
This test is used to evaluate survival rate or risk factors for individuals with myocardial infarction and peripheral vascular diseases. APO A-1 deficiency states include Tangier disease, HDL deficiency and hypoalpha-lipoprotein anemia. The apolipoprotein levels may be a better indicator of atherogenic risks than high-density lipoprotein (HDL), low-density lipoprotein (LDL) and very-low-density lipoprotein (VLDL).
